Use of voriconazole in a patient with aspergilloma caused by an itraconazole-resistant strain of Aspergillus fumigatus

被引：18
|
作者：
Dannaoui, E. [1 ]
Garcia-Hermoso, D.
Naccache, J. M.
Meneau, I.
Sanglard, D.
Bouges-Michel, C.
Valeyre, D.
Lortholary, O.
机构：
[1] Inst Pasteur, Ctr Natl Reference Mycol & Antifong, Unite Mycol Mol, CNRS,FRE2849, F-75724 Paris 15, France
[2] Univ Paris Descartes, Fac Med, AP HP, Hop European Georges Pompidou,Unite Parasitol Myc, F-75015 Paris, France
[3] Hop Avicenne, Serv Pneumol, F-93009 Bobigny, France
[4] Univ Hosp Lausanne, Inst Microbiol, CH-1011 Lausanne, Switzerland
[5] Hop Avicenne, Lab Parasitol Mycol, F-93009 Bobigny, France
[6] Univ Paris Descartes, Fac Med, Hop Necker Enfants Malad, AP HP,Serv Malad Infect & Trop, F-75743 Paris 15, France
来源：
JOURNAL OF MEDICAL MICROBIOLOGY | 2006年 / 55卷 / 10期
关键词：
D O I：
10.1099/jmm.0.46639-0
中图分类号：
Q93 [微生物学];
学科分类号：
071005 ; 100705 ;
摘要：
The case is reported of a patient with cavitary sarcoidosis complicated by an aspergilloma caused by an itraconazole-resistant strain of Aspergillus fumigatus, who was treated with voriconazole. The authors suggest that susceptibility testing of A. fumigatus strains is of value during long-term therapy with itraconazole, and that voriconazole may be a good option for treatment of patients infected with itraconazole-resistant strains of A. fumigatus.
引用
收藏
页码：1457 / 1459
页数：3
相关论文
共 50 条
  • [41] In-vitro activities of amphotericin B, itraconazole and voriconazole against 150 clinical and environmental Aspergillus fumigatus isolates
    Verweij, PE
    Mensink, M
    Rijs, AJMM
    Donnelly, JP
    Meis, JFGM
    Denning, DW
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1998, 42 (03) : 389 - 392
  • [42] Fatal invasive pulmonary aspergillosis caused by voriconazole-resistant Aspergillus tubingensis in a patient with solid tumor
    Harada, Sohei
    Ohkushi, Daisuke
    Nakano, Kenji
    Mitani, Hiroki
    Yamamoto, Yutaka
    Kamei, Katsuhiko
    Hayama, Brian
    JOURNAL OF INFECTION AND CHEMOTHERAPY, 2020, 26 (03) : 301 - 304
  • [43] In vitro efficacy of the combination of voriconazole and anidulafungin against voriconazole-resistant cyp51A mutants of Aspergillus fumigatus
    Krishnan-Natesan, Suganthini
    Wu, Wenjuan
    Chandrasekar, Pranatharthi H.
    DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 2012, 73 (02) : 135 - 137
  • [44] Increased expression of a novel Aspergillus fumigatus ABC transporter gene, atrF, in the presence of itraconazole in an itraconazole resistant clinical isolate
    Slaven, JW
    Anderson, MJ
    Sanglard, D
    Dixon, GK
    Bille, J
    Roberts, IS
    Denning, DW
    FUNGAL GENETICS AND BIOLOGY, 2002, 36 (03) : 199 - 206
  • [45] Soft Tissue Abscess Caused by Aspergillus Fumigatus in an Immunosuppressive Patient
    Dal, Tuba
    Tekin, Alicem
    Tekin, Recep
    Deveci, Ozcan
    Firat, Ugur
    Mete, Mahmut
    Dayan, Saim
    EUROPEAN JOURNAL OF GENERAL MEDICINE, 2013, 10 (02): : 118 - 122
  • [46] Aspergillus fumigatus-related Spondylodiscitis in a heart transplant patient successfully treated with voriconazole
    Weclawiak, H.
    Garrouste, C.
    Kamar, N.
    Linas, M. -D.
    Tall, P.
    Dambrin, C.
    Durand, D.
    Rostaing, L.
    TRANSPLANTATION PROCEEDINGS, 2007, 39 (08) : 2627 - 2628
  • [47] Pharmacokinetics of voriconazole in the cerebrospinal fluid of an immunocompromised patient with a brain abscess due to Aspergillus fumigatus
    Denes, E
    Pichon, N
    Debette-Gratien, M
    Bouteille, B
    Gaulier, JM
    CLINICAL INFECTIOUS DISEASES, 2004, 39 (04) : 603 - 604
  • [48] Aspergillosis due to Voriconazole Highly Resistant Aspergillus fumigatus and Recovery of Genetically Related Resistant Isolates From Domiciles
    van der Linden, Jan W. M.
    Camps, Simone M. T.
    Kampinga, Greetje A.
    Arends, Jan P. A.
    Debets-Ossenkopp, Yvette J.
    Haas, Pieter J. A.
    Rijnders, Bart J. A.
    Kuijper, Ed J.
    van Tiel, Frank H.
    Varga, Janos
    Karawajczyk, Anna
    Zoll, J.
    Melchers, Willem J. G.
    Verweij, Paul E.
    CLINICAL INFECTIOUS DISEASES, 2013, 57 (04) : 513 - 520
  • [49] COMPLETE ERADICATION OF ASPERGILLUS-FUMIGATUS FROM THE LUNG IN AN IMMUNOCOMPROMISED PATIENT BY ORAL ITRACONAZOLE
    MOORE, L
    ELLIS, DH
    SUPPIAH, R
    BYARD, RW
    TOOGOOD, IRG
    JOURNAL OF PAEDIATRICS AND CHILD HEALTH, 1993, 29 (02) : 141 - 143
  • [50] Nationwide survey of in vitro activities of itraconazole and voriconazole against clinical Aspergillus fumigatus isolates cultured between 1945 and 1998
    Verweij, PE
    Dorsthorst, DTAT
    Rijs, AJMM
    De Vries-Hospers, HG
    Meis, JFGM
    JOURNAL OF CLINICAL MICROBIOLOGY, 2002, 40 (07) : 2648 - 2650
12345